Henoch-schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report
- PMID: 37500944
- PMCID: PMC10827835
- DOI: 10.1007/s11739-023-03366-w
Henoch-schonlein purpura following exposure to SARS-CoV2 vaccine or infection: a systematic review and a case report
Abstract
Background: Henoch-Schonlein purpura (HSP) is an IgA-mediated systemic small-vessel vasculitis (IgAV) that typically presents with a variable tetrad of symptoms. HSP if often preceded by respiratory tract infections, vaccinations, drugs or malignancies. During the recent COVID-19 pandemic multiples cases of HSP have been described after both infection and vaccination for SARS-CoV2. This study aims to perform a systematic review of literature and describe an additional complicated case of de-novo HSP appeared after the administration of the third dose of a mRNA-SARS-CoV2 vaccination.
Methods: Electronic bibliographic research was performed to identify all the original reports describing cases of de-novo HSP or IgAV appeared after respiratory infection or vaccine administration for SARS-CoV2. We included all case series or case reports of patients who respected our inclusion and exclusion criteria.
Results: Thirty-eight publications met our pre-defined inclusion criteria, for an overall number of 44 patients. All patients presented with palpable purpura variable associated with arthralgia, abdominal pain or renal involvement. Increased levels of inflammation markers, mild leukocytosis and elevated D-dimer were the most common laboratory findings. Up to 50% of patients presented proteinuria and/or hematuria. Almost all skin biopsies showed leukocytoclastic vasculitis, with IgA deposits at direct immunofluorescence in more than 50% of cases.
Conclusions: Our results suggest that the immune response elicited by SARS-CoV2 vaccine or infection could play a role in the development of HSP. Current research suggests a possible role of IgA in immune hyperactivation, highlighted by early seroconversion to IgA found in some COVID-19 patients who develop IgA vasculitis.
Keywords: Henoch–Schonlein purpura; IgA-mediated vasculitis; SARS-CoV2 infection; SARS-CoV2 vaccination.
© 2023. The Author(s).
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
Similar articles
-
IgA vasculitis after COVID-19: a case-based review.Rheumatol Int. 2024 Jul;44(7):1353-1357. doi: 10.1007/s00296-024-05606-4. Epub 2024 May 13. Rheumatol Int. 2024. PMID: 38739223 Free PMC article. Review.
-
A child with Henoch-Schonlein purpura secondary to a COVID-19 infection.BMJ Case Rep. 2021 Jan 6;14(1):e239910. doi: 10.1136/bcr-2020-239910. BMJ Case Rep. 2021. PMID: 33408113 Free PMC article.
-
The Characteristics of Patients With COVID-19-Associated Pediatric Vasculitis: An International, Multicenter Study.Arthritis Rheumatol. 2023 Apr;75(4):499-506. doi: 10.1002/art.42411. Epub 2023 Jan 23. Arthritis Rheumatol. 2023. PMID: 36457245 Free PMC article.
-
SARS-CoV-2 Infection as a Possible Trigger for IgA-Associated Vasculitis: A Case Report.Children (Basel). 2023 Feb 10;10(2):344. doi: 10.3390/children10020344. Children (Basel). 2023. PMID: 36832473 Free PMC article.
-
Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review.J Dermatol. 2022 Jan;49(1):190-196. doi: 10.1111/1346-8138.16211. Epub 2021 Nov 5. J Dermatol. 2022. PMID: 34741345 Free PMC article. Review.
Cited by
-
Cutaneous vasculitis: insights into pathogenesis and histopathological features.Pathologica. 2024 Apr;116(2):119-133. doi: 10.32074/1591-951X-985. Pathologica. 2024. PMID: 38767544 Free PMC article. Review.
-
The relationship between the severity and complications of Henöch-Schönlein purpura in children and dietary inflammatory index: a retrospective cohort study.PeerJ. 2024 Sep 24;12:e18175. doi: 10.7717/peerj.18175. eCollection 2024. PeerJ. 2024. PMID: 39346080 Free PMC article.
-
An Investigation of the Relationship between Henoch-Schönlein Purpura and Viral Infection in Korea Using the Health Insurance Database.J Clin Med. 2024 Feb 24;13(5):1290. doi: 10.3390/jcm13051290. J Clin Med. 2024. PMID: 38592700 Free PMC article.
-
Cutaneous Adverse Events Following COVID-19 Vaccination in Japan: A Questionnaire Survey.Cureus. 2025 Mar 8;17(3):e80257. doi: 10.7759/cureus.80257. eCollection 2025 Mar. Cureus. 2025. PMID: 40196074 Free PMC article.
References
-
- Ruperto N, Ozen S, Pistorio A, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood takayasu arteritis: ankara 2008. Part I: overall methodology and clinical characterisation. Ann Rheum Dis. 2010;69:790–797. doi: 10.1136/ard.2009.116624. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous